Search Results
Found 2 results
510(k) Data Aggregation
(37 days)
This device is a nonprecious, nickel-chromium-molybdenum based ceramic casting alloy for use in the construction of cast ceramic bonded crown and bridge prosthetic devices. According to 21 CFR Ch.1 (4-1-89 Ed.) Part 872. the classification name for this device is Base Metal Alloy, a Class II device.
nonprecious, nickel-chromium-molybdenum based ceramic casting alloy
The provided document is an FDA 510(k) clearance letter for a dental alloy named "VeraBond 2." This document does not contain information about acceptance criteria or a study proving the device meets those criteria, as it is a regulatory clearance letter rather than a technical study report.
Therefore, I cannot provide the requested information from this document. The letter simply states that the FDA has reviewed the device and determined it to be "substantially equivalent" to predicate devices already on the market, thus allowing it to be marketed. It refers to the "indications for use" as stated in an enclosure, but the enclosure itself (which would detail the device's properties and intended use) is not present in the provided text.
Ask a specific question about this device
(48 days)
This device is a nonprecious, nickel-chromium-molybdenum based ceramic casting alloy for use in the construction of cast ceramic bonded crown and bridge prosthetic devices. According to 21 CFR Ch.1 (4-1-89 Ed.) Part 872. the classification name for this device is Base Metal Alloy, a Class II device.
This device is a nonprecious, nickel-chromium-molybdenum based ceramic casting alloy for use in the construction of cast ceramic bonded crown and bridge prosthetic devices.
This document is a 510(k) premarket notification letter from the FDA regarding a dental alloy, Verabond 2V. It confirms that the device is substantially equivalent to legally marketed predicate devices.
The information requested in the prompt, specifically related to acceptance criteria and a study proving the device meets those criteria, is not present in the provided document.
This letter is a regulatory approval notice based on substantial equivalence, not a detailed report of a clinical or performance study with specific acceptance criteria.
Therefore, I cannot provide the requested table and study details.
Ask a specific question about this device
Page 1 of 1